Clinical	B:C2826293
significance	I:C2826293
of	O
human	O
intestinal	O
spirochetosis	O
:	O
a	O
retrospective	O
study	I:C0035363
.	O

Clinical	O
significance	I:C2826293
of	O
human	B:C0086418
intestinal	O
spirochetosis	O
:	O
a	O
retrospective	O
study	I:C0035363
.	O

Clinical	O
significance	I:C2826293
of	O
human	O
intestinal	B:C0021853
spirochetosis	O
:	O
a	O
retrospective	O
study	I:C0035363
.	O

Clinical	O
significance	I:C2826293
of	O
human	O
intestinal	O
spirochetosis	B:C0037974
:	O
a	O
retrospective	O
study	I:C0035363
.	O

Clinical	O
significance	I:C2826293
of	O
human	O
intestinal	O
spirochetosis	O
:	O
a	O
retrospective	B:C0035363
study	I:C0035363
.	O

The	O
clinical	O
and	O
pathological	O
features	O
of	O
human	B:C0086418
intestinal	O
spirochetosis	O
(	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
)	O
are	O
not	O
well	O
known	O
.	O

The	O
clinical	O
and	O
pathological	O
features	O
of	O
human	O
intestinal	B:C0021853
spirochetosis	O
(	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
)	O
are	O
not	O
well	O
known	O
.	O

The	O
clinical	O
and	O
pathological	O
features	O
of	O
human	O
intestinal	O
spirochetosis	B:C0037974
(	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
)	O
are	O
not	O
well	O
known	O
.	O

The	O
clinical	O
and	O
pathological	O
features	O
of	O
human	O
intestinal	O
spirochetosis	O
(	O
human	B:C0037974
intestinal	I:C0037974
spirochetosis	I:C0037974
)	O
are	O
not	O
well	O
known	O
.	O

Here	O
we	O
report	O
55	O
patients	O
with	O
human	B:C0037974
intestinal	I:C0037974
spirochetosis	I:C0037974
who	O
were	O
diagnosed	O
at	O
our	O
institution	O
during	O
the	O
past	O
5	O
years	O
.	O

Here	O
we	O
report	O
55	O
patients	O
with	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
who	O
were	O
diagnosed	B:C0011900
at	O
our	O
institution	O
during	O
the	O
past	O
5	O
years	O
.	O

Here	O
we	O
report	O
55	O
patients	O
with	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
who	O
were	O
diagnosed	O
at	O
our	O
institution	B:C0018704
during	O
the	O
past	O
5	O
years	O
.	O

Seven	O
patients	O
presented	O
with	O
symptoms	B:C1457887
such	O
as	O
abdominal	O
pain	I:C0000737
or	O
diarrhea	O
,	O
while	O
the	O
others	O
were	O
incidentally	O
diagnosed	O
during	O
screening	O
colonoscopy	I:C1882982
.	O

Seven	O
patients	O
presented	O
with	O
symptoms	O
such	O
as	O
abdominal	B:C0000737
pain	I:C0000737
or	O
diarrhea	O
,	O
while	O
the	O
others	O
were	O
incidentally	O
diagnosed	O
during	O
screening	O
colonoscopy	I:C1882982
.	O

Seven	O
patients	O
presented	O
with	O
symptoms	O
such	O
as	O
abdominal	O
pain	I:C0000737
or	O
diarrhea	B:C0011991
,	O
while	O
the	O
others	O
were	O
incidentally	O
diagnosed	O
during	O
screening	O
colonoscopy	I:C1882982
.	O

Seven	O
patients	O
presented	O
with	O
symptoms	O
such	O
as	O
abdominal	O
pain	I:C0000737
or	O
diarrhea	O
,	O
while	O
the	O
others	O
were	O
incidentally	O
diagnosed	B:C0011900
during	O
screening	O
colonoscopy	I:C1882982
.	O

Seven	O
patients	O
presented	O
with	O
symptoms	O
such	O
as	O
abdominal	O
pain	I:C0000737
or	O
diarrhea	O
,	O
while	O
the	O
others	O
were	O
incidentally	O
diagnosed	O
during	O
screening	B:C1882982
colonoscopy	I:C1882982
.	O

Most	O
patients	O
had	O
non-specific	O
endoscopic	B:C0014245
findings	O
,	O
including	O
intestinal	O
edema	I:C1142262
or	O
erosion	O
.	O

Most	O
patients	O
had	O
non-specific	O
endoscopic	O
findings	B:C0243095
,	O
including	O
intestinal	O
edema	I:C1142262
or	O
erosion	O
.	O

Most	O
patients	O
had	O
non-specific	O
endoscopic	O
findings	O
,	O
including	O
intestinal	B:C1142262
edema	I:C1142262
or	O
erosion	O
.	O

Most	O
patients	O
had	O
non-specific	O
endoscopic	O
findings	O
,	O
including	O
intestinal	O
edema	I:C1142262
or	O
erosion	B:C1959609
.	O

The	O
diagnosis	B:C0011900
of	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
was	O
histologically	O
confirmed	O
via	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
,	O
periodic	O
acid-Schiff	I:C0523213
staining	I:C0523213
,	O
and	O
/	O
or	O
immunohistochemistry	O
using	O
anti-Treponema	O
pallidum	I:C0003241
antibody	I:C0003241
.	O

The	O
diagnosis	O
of	O
human	B:C0037974
intestinal	I:C0037974
spirochetosis	I:C0037974
was	O
histologically	O
confirmed	O
via	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
,	O
periodic	O
acid-Schiff	I:C0523213
staining	I:C0523213
,	O
and	O
/	O
or	O
immunohistochemistry	O
using	O
anti-Treponema	O
pallidum	I:C0003241
antibody	I:C0003241
.	O

The	O
diagnosis	O
of	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
was	O
histologically	O
confirmed	O
via	O
hematoxylin	B:C0523207
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
,	O
periodic	O
acid-Schiff	I:C0523213
staining	I:C0523213
,	O
and	O
/	O
or	O
immunohistochemistry	O
using	O
anti-Treponema	O
pallidum	I:C0003241
antibody	I:C0003241
.	O

The	O
diagnosis	O
of	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
was	O
histologically	O
confirmed	O
via	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
,	O
periodic	B:C0523213
acid-Schiff	I:C0523213
staining	I:C0523213
,	O
and	O
/	O
or	O
immunohistochemistry	O
using	O
anti-Treponema	O
pallidum	I:C0003241
antibody	I:C0003241
.	O

The	O
diagnosis	O
of	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
was	O
histologically	O
confirmed	O
via	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
,	O
periodic	O
acid-Schiff	I:C0523213
staining	I:C0523213
,	O
and	O
/	O
or	O
immunohistochemistry	B:C0021044
using	O
anti-Treponema	O
pallidum	I:C0003241
antibody	I:C0003241
.	O

The	O
diagnosis	O
of	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
was	O
histologically	O
confirmed	O
via	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
,	O
periodic	O
acid-Schiff	I:C0523213
staining	I:C0523213
,	O
and	O
/	O
or	O
immunohistochemistry	O
using	O
anti-Treponema	B:C0003241
pallidum	I:C0003241
antibody	I:C0003241
.	O

Among	O
the	O
55	O
patients	O
,	O
five	O
were	O
diagnosed	B:C0011900
with	O
diseases	O
other	O
than	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
(	O
amoebic	O
colitis	I:C0013370
,	O
three	O
;	O
ulcerative	O
colitis	I:C0009324
,	O
one	O
)	O
.	O

Among	O
the	O
55	O
patients	O
,	O
five	O
were	O
diagnosed	O
with	O
diseases	B:C0012634
other	O
than	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
(	O
amoebic	O
colitis	I:C0013370
,	O
three	O
;	O
ulcerative	O
colitis	I:C0009324
,	O
one	O
)	O
.	O

Among	O
the	O
55	O
patients	O
,	O
five	O
were	O
diagnosed	O
with	O
diseases	O
other	O
than	O
human	B:C0037974
intestinal	I:C0037974
spirochetosis	I:C0037974
(	O
amoebic	O
colitis	I:C0013370
,	O
three	O
;	O
ulcerative	O
colitis	I:C0009324
,	O
one	O
)	O
.	O

Among	O
the	O
55	O
patients	O
,	O
five	O
were	O
diagnosed	O
with	O
diseases	O
other	O
than	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
(	O
amoebic	B:C0013370
colitis	I:C0013370
,	O
three	O
;	O
ulcerative	O
colitis	I:C0009324
,	O
one	O
)	O
.	O

Among	O
the	O
55	O
patients	O
,	O
five	O
were	O
diagnosed	O
with	O
diseases	O
other	O
than	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
(	O
amoebic	O
colitis	I:C0013370
,	O
three	O
;	O
ulcerative	B:C0009324
colitis	I:C0009324
,	O
one	O
)	O
.	O

Sixteen	O
patients	O
were	O
treated	B:C0332293
with	I:C0332293
either	O
amoxicillin	O
or	O
metronidazole	O
;	O
only	O
metronidazole	O
proved	O
to	O
be	O
effective	O
.	O

Sixteen	O
patients	O
were	O
treated	O
with	I:C0332293
either	O
amoxicillin	B:C0002645
or	O
metronidazole	O
;	O
only	O
metronidazole	O
proved	O
to	O
be	O
effective	O
.	O

Sixteen	O
patients	O
were	O
treated	O
with	I:C0332293
either	O
amoxicillin	O
or	O
metronidazole	B:C0025872
;	O
only	O
metronidazole	O
proved	O
to	O
be	O
effective	O
.	O

Sixteen	O
patients	O
were	O
treated	O
with	I:C0332293
either	O
amoxicillin	O
or	O
metronidazole	O
;	O
only	O
metronidazole	B:C0025872
proved	O
to	O
be	O
effective	O
.	O

The	O
clinical	B:C2826293
significance	I:C2826293
of	O
asymptomatic	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
remains	O
unknown	O
.	O

The	O
clinical	O
significance	I:C2826293
of	O
asymptomatic	B:C0231221
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
remains	O
unknown	O
.	O

The	O
clinical	O
significance	I:C2826293
of	O
asymptomatic	O
human	B:C0037974
intestinal	I:C0037974
spirochetosis	I:C0037974
remains	O
unknown	O
.	O

Some	O
case	B:C0085973
reports	I:C0085973
suggest	O
a	O
risk	O
for	O
increased	O
severity	O
in	O
patients	O
with	O
immunodeficiency	O
and	O
/	O
or	O
sexually	O
transmitted	I:C0036916
diseases	I:C0036916
.	O

Some	O
case	O
reports	I:C0085973
suggest	O
a	O
risk	O
for	O
increased	O
severity	O
in	O
patients	O
with	O
immunodeficiency	B:C0021051
and	O
/	O
or	O
sexually	O
transmitted	I:C0036916
diseases	I:C0036916
.	O

Some	O
case	O
reports	I:C0085973
suggest	O
a	O
risk	O
for	O
increased	O
severity	O
in	O
patients	O
with	O
immunodeficiency	O
and	O
/	O
or	O
sexually	B:C0036916
transmitted	I:C0036916
diseases	I:C0036916
.	O

Therefore	O
,	O
aggressive	B:C0087111
treatment	I:C0087111
for	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
should	O
be	O
considered	O
,	O
particularly	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
patients	O
.	O

Therefore	O
,	O
aggressive	O
treatment	I:C0087111
for	O
human	B:C0037974
intestinal	I:C0037974
spirochetosis	I:C0037974
should	O
be	O
considered	O
,	O
particularly	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
patients	O
.	O

Therefore	O
,	O
aggressive	O
treatment	I:C0087111
for	O
human	O
intestinal	I:C0037974
spirochetosis	I:C0037974
should	O
be	O
considered	O
,	O
particularly	O
in	O
high	B:C0332167
-	I:C0332167
risk	I:C0332167
patients	O
.	O

